← Back to headlines
Zealand Pharma Shares Fall After Weight-Loss Drug Trial Setback
Zealand Pharma's shares dropped significantly by 32% following disappointing mid-stage trial results for a weight-loss treatment being developed with Roche.
6 Mar, 10:24 — 6 Mar, 13:52
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
marketwatchFT
Right
Far R
Geographic diversity— 2 regions9/34
US1UK1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
FTVery High10d ago
Biotech group’s shares hit by weight-loss drug setback
Zealand Pharma falls 32% following mid-stage trial results for treatment being developed with Roche
Read full article →marketwatchMostly Factual10d ago
Disappointing weight-loss-drug trial results from Zealand Pharma send shares tumbling
Zealand Pharma obesity drug showed disappointing weight loss in a Phase 2 trial.
By Jaimy Lee
Read full article →Coverage Timeline
First report: FT · 6 Mar, 10:24|Full coverage: All 2 sources within 3h|Window: 3h
Left-leaningCenterRight-leaning
